1-10 of 10
Bo Lu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-047: Early T cell responses are enhanced by heterogenous dose delivery in a murine model of head and neck cancer

Jennifer Mourtada, Adam Raben, James Keller, Neil Hockstien, Yan Yu, Bo Lu, Firas Mourtada
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-047.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-047
Published: 15 April 2021
View article titled, Abstract PO-047: Early T cell responses are enhanced by heterogenous dose delivery in a murine model of head and neck cancer
Journal Articles

SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer

Zhen Tao, Neal S. McCall, Norbert Wiedemann, Grégoire Vuagniaux, Zhiyong Yuan, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (3): 1113–1124.
https://doi.org/10.1158/1078-0432.CCR-17-3852
Published: 01 February 2019
View article titled, SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer
Open the PDF for SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer

Neal S. McCall, Adam P. Dicker, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1271–1276.
https://doi.org/10.1158/1078-0432.CCR-17-3269
Published: 14 March 2018
View article titled, Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer
Open the PDF for Beyond Concurrent Chemoradiation: The Emerging Role of PD-1/PD-L1 Inhibitors in Stage III Lung Cancer in another window
Journal Articles

Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers In Vitro and In Vivo

Zhen Tao, Justin M. Le Blanc, Chenguang Wang, Tingting Zhan, Hongqing Zhuang, Ping Wang, Zhiyong Yuan, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 122–133.
https://doi.org/10.1158/1078-0432.CCR-15-0589
Published: 03 January 2016
View article titled, Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for Coadministration of Trametinib and Palbociclib Radiosensitizes KRAS-Mutant Non–Small Cell Lung Cancers <em>In Vitro</em> and <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase

Yi-He Ling, Miguel Aracil, Yiyu Zou, Ziqiang Yuan, Bo Lu, José Jimeno, Ana Maria Cuervo, Roman Perez-Soler
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5353–5366.
https://doi.org/10.1158/1078-0432.CCR-10-1948
Published: 14 August 2011
View article titled, PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase
Open the PDF for PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase in another window
Journal Articles

Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model

Kwang Woon Kim, Luigi Moretti, Lauren Rhea Mitchell, Dae Kwang Jung, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (19): 6096–6105.
https://doi.org/10.1158/1078-0432.CCR-09-0589
Published: 30 September 2009
View article titled, Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model
Open the PDF for Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model in another window
Journal Articles

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer

Robert Mutter, Bo Lu, David P. Carbone, Ildiko Csiki, Luigi Moretti, David H. Johnson, Jason D. Morrow, Alan B. Sandler, Yu Shyr, Fei Ye, Hak Choy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2158–2165.
https://doi.org/10.1158/1078-0432.CCR-08-0629
Published: 16 March 2009
View article titled, A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer
Open the PDF for A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer in another window
Journal Articles

Effects of a Topically Applied Bioadhesive Berry Gel on Loss of Heterozygosity Indices in Premalignant Oral Lesions

Brian S. Shumway, Laura A. Kresty, Peter E. Larsen, Jared C. Zwick, Bo Lu, Henry W. Fields, Russell J. Mumper, Gary D. Stoner, Susan R. Mallery
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (8): 2421–2430.
https://doi.org/10.1158/1078-0432.CCR-07-4096
Published: 15 April 2008
View article titled, Effects of a Topically Applied Bioadhesive Berry Gel on Loss of Heterozygosity Indices in Premalignant Oral Lesions
Open the PDF for Effects of a Topically Applied Bioadhesive Berry Gel on Loss of Heterozygosity Indices in Premalignant Oral Lesions in another window
Includes: Supplementary data
Journal Articles

Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models

Jeffrey M. Albert, Carolyn Cao, Kwang Woon Kim, Christopher D. Willey, Ling Geng, Dakai Xiao, Hong Wang, Alan Sandler, David H. Johnson, Alexander D. Colevas, Jennifer Low, Mace L. Rothenberg, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3033–3042.
https://doi.org/10.1158/1078-0432.CCR-06-2872
Published: 15 May 2007
View article titled, Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models
Open the PDF for Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models in another window
Journal Articles

Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation

Wu Zhang, David J. Park, Bo Lu, Dong Yun Yang, Michael Gordon, Susan Groshen, Jim Yun, Oliver A. Press, Daniel Vallböhmer, Katrin Rhodes, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 600–605.
https://doi.org/10.1158/1078-0432.600.11.2
Published: 08 February 2005
View article titled, Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation
Open the PDF for Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation in another window